文献速递主动脉疾病

多层血流调节器支架治疗B型主动脉夹层的单中心一年结果

One-Year Single-Center Results of the Multilayer Flow Modulator Stents for the Treatment of Type B Aortic Dissection.
PubMed 文献 · J Endovasc Ther · 2020-09-01

报告23例复杂B型主动脉夹层患者接受多层血流调节器(MFM)治疗的单中心经验,随访至36个月。12个月时免于破裂或主动脉相关死亡为100%,免于全因死亡为95.7%,免于再干预为91.3%。主动脉重塑表现为真腔体积进行性增加(75.9%)和假腔体积减少(42.8%)。

要点

  • MFM治疗复杂B型主动脉夹层初始技术成功率为91.3%。
  • 12个月免于破裂或主动脉相关死亡为100%,免于全因死亡为95.7%。
  • 随访期间真腔体积增加75.9%、假腔体积减少42.8%,无器械相关神经或全身并发症。

核心结论

  • MFM为复杂急性、亚急性和慢性B型主动脉夹层提供了安全可行的治疗选择,技术成功率高、死亡率低且主动脉重塑活跃。

研究设计与样本

  • 单中心系列研究,36个月期间纳入23例复杂B型主动脉夹层患者(中位年龄53岁;20例男性;2例急性、5例亚急性、16例慢性),接受MFM治疗。
  • 主要终点为破裂或夹层相关死亡、全因死亡和再干预,采用Kaplan-Meier法评估并报告95%CI;次要结局包括技术成功、不良事件和主动脉重塑。
  • 术前、术后即刻及每年至36个月收集临床和影像数据,并使用计算流体动力学(CFD)分析。

主要发现

  • 初始技术成功率为91.3%。
  • 12个月时免于破裂或主动脉相关死亡的估计值为100%,免于全因死亡为95.7%,免于再干预为91.3%。
  • 未发生器械相关神经或全身并发症,随访期间无需额外再干预。
  • MFM覆盖的144个分支均保持通畅。
  • 形态学分析显示真腔体积进行性增加(75.9%,p<0.001),假腔体积减少(42.8%,p<0.001);CFD分析显示层流增加。

临床怎么用

  • 对于复杂B型主动脉夹层(包括急性、亚急性和慢性),MFM可作为安全可行的治疗选项,具有高技术成功率和低死亡率。
  • 术后需定期影像随访评估主动脉重塑(真腔增加、假腔减少)和分支通畅情况。

局限性

  • 单中心小样本系列(23例),需进一步研究在更大患者队列中阐明MFM的长期安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report a single-center series of patients with type B aortic dissection treated with the Multilayer Flow Modulator (MFM). MATERIALS AND METHODS: Over a 36-month period, 23 patients (median age 53 years; 20 men) with complicated type B aortic dissections (2 acute, 5 subacute, and 16 chronic) were treated with the MFM. Primary endpoints of rupture or dissection-related death, overall mortality, and reintervention were evaluated using the Kaplan-Meier method; estimates for freedom from the endpoints are reported with the 95% confidence interval (CI). Secondary outcomes included technical success, adverse events, and aortic remodeling. Clinical and imaging data were collected preoperatively, directly postoperatively, and annually to 36 months for analysis using computational fluid dynamics (CFD). RESULTS: Initial technical success was 91.3%. The estimates of the endpoints at 12 months were 100% for freedom from rupture or aortic-related death, 95.7% for freedom from overall mortality, and 91.3% for freedom from reintervention. No device-related neurological or systemic complications occurred, and no additional reinterventions were needed during follow-up. A total of 144 branches overstented by the MFM remained patent. Morphologic analysis of the aortic dissection showed progressive true lumen volume increase (75.9%, p<0.001) with concomitant false lumen volume decrease (42.8%, p<0.001); the CFD analyses showed increased laminar flow. CONCLUSION: In the current series, the MFM provided a safe and feasible treatment option for complicated acute, subacute, and chronic type B aortic dissections, with high technical success, low mortality, and active aortic remodeling. Further studies should elucidate the long-term safety of the MFM and its effectiveness in a larger patient cohort.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Costache VS, Meekel JP, Costache A, et al. One-Year Single-Center Results of the Multilayer Flow Modulator Stents for the Treatment of Type B Aortic Dissection. J Endovasc Ther. 2020. PMID: 32873130. doi:10.1177/1526602820950720

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。